DENVER, Colo. – HERA Women’s Cancer Foundation has elected Dr. Kian Behbakht, renowned ovarian cancer doctor and researcher, to its board of directors. HERA, an acronym for Health, Empowerment, Research and Awareness, focuses on education and awareness of the symptoms of ovarian cancer, promotes early detection and also supports cutting-edge ovarian cancer research.
Dr. Behbakht, who is currently associate professor of gynecologic oncology and basic reproductive sciences at the University of Colorado Health Sciences Center in Denver, has also taught at the University of Pennsylvania and Rush Medical College and is board-certified in obstetrics and gynecology as well as gynecologic oncology.
A widely published and a highly sought-after lecturer on a wide range of subjects pertaining to ovarian cancer and ovarian cancer research, Dr. Behbakht brings a wealth of expertise and knowledge about the disease to HERA’s board of directors. He will serve on the Science and Community Grants Committee and the Education and Awareness Committee, providing invaluable insight into the complexities of ovarian cancer.
Dr. Behbakht says, “I am deeply committed to the mission and philosophy of the HERA Women’s Cancer Foundation and am honored to be a part of this important organization. HERA provides invaluable services to those dealing with ovarian cancer, and I am proud to be a part of that work.”
About the HERA Foundation
The HERA Foundation is a 501 (c)(3) non-profit organization, whose mission is to stop the loss of women and girls to ovarian cancer by empowering women to take control of their health, empowering the medical community to find new directions in ovarian cancer research and empowering communities to provide support. For more information, visit www.herafoundation.org.
